KKR launches New York medical technology platform Allyntra
KKR has formed Allyntra, a New York-based medical technology platform, with Robbie Atkinson set to become chief executive.
By Rafael Ortiz · Fintech Correspondent
· 2 min read
KKR has launched Allyntra, a New York-based medical technology platform, PE Hub reported. The move adds a new healthcare-focused platform to the private equity firm’s portfolio activity, with leadership appointments named at launch.
According to PE Hub, Robbie Atkinson will be appointed chief executive officer of Allyntra. Brian Highley will serve as chairman.
Atkinson most recently worked as chief executive officer and president of Medical Manufacturing Technologies, PE Hub reported. The report did not disclose financial terms, investors alongside KKR, or the specific operating scope of Allyntra beyond its position as a medical technology platform.
Oliver Laubscher will also join Allyntra’s board of directors as part of the launch, according to PE Hub. Laubscher will transition from his role as chief executive officer of Precipart.
Platform model
In private equity, a platform company is typically used as an operating base for building a business in a targeted sector. Sponsors may use a platform to pursue organic expansion, acquisitions, or both, depending on the company’s strategy and the investor’s capital plan.
PE Hub’s report did not specify whether Allyntra will pursue acquisitions, internal growth initiatives, or a combination of approaches. It also did not provide details on Allyntra’s product categories, customers, revenue, workforce, or manufacturing footprint.
The formation of Allyntra places KKR’s latest activity within healthcare and medical technology, sectors where private capital often focuses on specialist manufacturing, clinical supply chains, device components, and services tied to regulated end markets. Those broader sector dynamics were not detailed in PE Hub’s report, which focused on the launch and executive appointments.
KKR is a global investment firm with activities across private equity and other asset classes. PE Hub identified the firm as the sponsor behind the launch of Allyntra.
This story draws on original reporting from PE Hub.